[1]
null Abe S , Yamaguchi S , Sato Y , Harada K . 2016. Sphere-derived multipotent progenitor cells obtained from human oral mucosa are enriched in neural crest cells. Stem Cells Translational Medicine, 5(1): 117–128.
null Ai Z , Xiang Z , Li Y , Liu G , Wang H , Zheng Y , Qiu X , Zhao S , Zhu X , Li Y , Ji W , Li T . 2016. Conversion of monkey fibroblasts to transplantable telencephalic neuroepithelial stem cells. Biomaterials, 77: 53–65.
null Bacigaluppi M , Russo GL , Peruzzotti-Jametti L , Rossi S , Sandrone S , Butti E , De Ceglia R , Bergamaschi A , Motta C , Gallizioli M , Studer V , Colombo E , Farina C , Comi G , Politi LS , Muzio L , Villani C , Invernizzi RW , Hermann DM , Centonze D , Martino G . 2016. Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes. The Journal of Neuroscience, 36(41): 10529–10544.
null Barker RA , Parmar M , Studer L , Takahashi J . 2017. Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era. Cell Stem Cell, 21(5): 569–573.
null Bentlage C , Nikkhah G , Cunningham MG , Bjorklund A . 1999. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Experimental Neurology, 159(1): 177–190.
null Bergstrom R , Strom S , Holm F , Feki A , Hovatta O . 2011. Xeno-free culture of human pluripotent stem cells. Methods in Molecular Biology, 767: 125–136.
null Bernstein AI, Garrison SP , Zambetti GP , O'malley KL . 2011. 6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death. Molecular Neurodegenerati., 6(1): 2–10.
null Bjugstad KB , Redmond DE, Teng YD , Elsworth JD , Roth RH , Blanchard BC , Snyder EY , Sladek JR . 2005. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: A return to control measures. Cell Transplantation, 14(4): 183–192.
null Bjugstad KB , Teng YD , Redmond DE, Jr., Elsworth JD , Roth RH , Cornelius SK , Snyder EY , Sladek JR , Jr . 2008. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Experimental Neurology, 211(2): 362–369.
null Bove J , Perier C . 2012. Neurotoxin-based models of Parkinson's disease. Neuroscience, 211: 51–76.
null Camus S , Ko WKD , Pioli E , Bezard E . 2015. Why bother using non-human primate models of cognitive disorders in translational research?. Neurobiology of Learning and Memory, 124: 123–129.
null Chiu AY , Hall ZW . 2006. Stem cell research: the California experience. The Journal of Neuroscience, 26(25): 6661–6663.
null Choi DH , Kim JH , Kim SM , Kang K , Han DW , Lee J . 2017. Therapeutic potential of induced neural stem cells for Parkinson's disease. International Journal of Molecular Sciences, 18(1): E224.
null Cicchetti F , Drouin-Ouellet J , Gross RE . 2010. Viability of the rotenone model in question. Trends in Pharmacological Sciences, 31(4): 142–143.
null Cimdins K , Waugh HS , Chrysostomou V , Lopez Sanchez MIG , Johannsen VA , Cook MJ , Crowston JG , Hill AF , Duce JA , Bush AI, Trounce IA . 2019. Amyloid precursor protein mediates neuronal protection from rotenone toxicity. Molecular Neurobiology, 2(3): 55–62.
null Cowen D . 1986. The melanoneurons of the human cerebellum (nucleus pigmentosus cerebellaris) and homologues in the monkey. Journal of Neuropathology and Experimental Neurology, 45(3): 205–221.
null Coizet V , Heilbronner SR , Carcenac C , Mailly P , Lehman JF , Savasta M , David O , Deniau JM , Groenewegen HJ , Haber SN . 2017. Organization of the anterior limb of the internal capsule in the rat. The Journal of Neuroscience, 37(10): 2539–2554.
null Collier TJ , Redmond DE, Steece-Collier K , Lipton JW , Manfredsson FP . 2016. Is alpha-synuclein loss-of-function a contributor to Parkinsonian pathology? Evidence from Non-human Primates. Frontiers in Neuroscience, 10(5): 12–20.
null Cyranoski D . 2017. Trials of embryonic stem cells to launch in China. Nature, 546(7656): 15–16.
null Dauer W , Przedborski S . 2003. Parkinson's disease: Mechanisms and models. Neuron, 39(6): 889–909.
null Didier ES , Maclean AG , Mohan M , Didier PJ , Lackner AA , Kuroda MJ . 2016. Contributions of nonhuman primates to research on aging. Veterinary Pathology, 53(2): 277–290.
null Emborg ME . 2004. Evaluation of animal models of Parkinson's disease for neuroprotective strategies. Journal of Neuroscience Methods, 139(2): 121–143.
null Drouin-Ouellet J . 2014. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease. Neurodegenerative disease management, 4(4): 297–307.
null Howson PA , Johnston TH , Ravenscroft P , Hill MP , Su J , Brotchie JM , Koprich JB . 2019. Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics, 369(3): 364–374.
null Emborg ME . 2017. Nonhuman primate models of neurodegenerative disorders. Ilar Journal, 58(2): 190–201.
null Eslamboli A , Baker HF , Ridley RM , Annett LE . 2003. Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys. Experimental Neurology, 183(2): 418–429.
null Eslamboli A , Georgievska B , Ridley RM , Baker HF , Muzyczka N , Burger C , Mandel RJ , Annett L , Kirik D . 2005. Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. The Journal of Neuroscience, 25(4): 769–777.
null Eslamboli A , Romero-Ramos M , Burger C , Bjorklund T , Muzyczka N , Mandel RJ , Baker H , Ridley RM , Kirik D . 2007. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain, 130: 799–815.
null Fallahi-Sichani M , Soleimani M , Najafi SMA , Kiani J , Arefian E , Atashi A . 2007. In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. Cell Biology International, 31(3): 299–303.
null Hallett PJ , Deleidi M , Astradsson A , Smith GA , Cooper O , Osborn TM , Sundberg M , Moore MA , Perez-Torres E , Brownell AL , Schumacher JM , Spealman RD , Isacson O . 2015. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease. Cell Stem Cell, 16(3): 269–274.
null Han F , Wang W , Chen B , Chen C , Li S , Lu X , Duan J , Zhang Y , Zhang YA , Guo W , Li G . 2015. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease. Cytotherapy, 17(5): 665–679.
null Handschel J , Naujoks C , Depprich R , Lammers L , Kübler N , Meyer U , Wiesmann H . 2011. Embryonic stem cells in scaffold-free three-dimensional cell culture: osteogenic differentiation and bone generation. Head & Face Medicine, 7(1): 12–12.
null Hayashi T , Wakao S , Kitada M , Ose T , Watabe H , Kuroda Y , Mitsunaga K , Matsuse D , Shigemoto T , Ito A , Ikeda H , Fukuyama H , Onoe H , Tabata Y , Dezawa M . 2013. Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques. Journal of Clinical Investigation, 123(1): 272–284.
null Huang B , Wu S , Wang Z , Ge L , Rizak J , Wu J , Li J , Xu L , Lv L , Yin Y , Hu X , Li H . 2018. Phosphorylated α-synuclein accumulations and lewy body-like pathology distributed in Parkinson's disease-related brain areas of aged rhesus monkeys treated with MPTP. Neuroscience, 379: 302–315.
null Johnson ME , Stringer A , Bobrovskaya L . 2018. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease. Neurotoxicology, 65: 174–185.
null Jiang PZ , Dickson DW . 2018. Parkinson's disease: experimental models and reality. Acta Neuropathologica, 135(1): 13–32.
null Kauhausen JA , Thompson LH , Parish CL . 2015. Chondroitinase improves midbrain pathway reconstruction by transplanted dopamine progenitors in parkinsonian mice. Molecular & Cellular Neuroscience, 69: 22–29.
null Kern DS , Maclean KN , Jiang H , Synder EY , Sladek JR , Jr., Bjugstad KB . 2011. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn down syndrome mice. Cell Transplantation, 20(3): 371–379.
null Kern R , Garitaonandia I , Gonzalez R , Sherman G , Noskov A , Cardiff D , Christiansen-Weber T , Semechkin A , Braine E , Shahrul A , Nair G , Evans A . 2018. Interim clinical assessment of a neural stem cell Based therapy for Parkinson's disease. Neurology, 90(1): 12–12.
null Kikuchi T , Morizane A , Doi D , Magotani H , Onoe H , Hayashi T , Mizuma H , Takara S , Takahashi R , Inoue H , Morita S , Yamamoto M , Okita K , Nakagawa M , Parmar M , Takahashi J . 2017. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature, 548(7669): 592–596.
null Kim SH , Hong JY , Joo SY , Kim JH , Moon SY , Yoon HS , Kim DH , Chung HM , Choi SJ . 2004. Derivation of neural precursor cells from human embryonic stem cells. Reproductive & Developmental Biology, 28(4): 247–252.
null Kim SU , Lee HJ , Kim YB . 2013. Neural stem cell-based treatment for neurodegenerative diseases. Neuropathology, 33(5): 491–504.
null Kim JH , Auerbach JM , Rodriguez-Gomez JA , Velasco I , Gavin D , Lumelsky N , Lee SH , Nguyen J , Sanchez-Pernaute R , Bankiewicz K , Mckay R . 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature, 418(6893): 50–56.
null Kirik D , Annett L , Burger C , Muzyczka N , Mandel RJ , Bj?rklund A . 2003. Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein: a new primate model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America, 100(5): 2884–2889.
null Koprich JB , Johnston TH , Reyes G , Omana V , Brotchie JM . 2016. Towards a non-human primate model of alpha-synucleinopathy for development of therapeutics for Parkinson's disease: optimization of AAV1/2 delivery parameters to drive sustained expression of alpha synuclein and dopaminergic degeneration in Macaque. PLoS One, 11(11): e0167235.
null Koprich JB , Johnston TH , Su J , Fox SH , Ma YL , Zuo CT , Guan YH , Brotchie JM . 2017. A non-human primate model of Parkinson's disease based on viral vector mediated overexpression of alpha-synuclein. Acta Pharmacologica Sinica, 38(7): 1090–1090.
null Kostrzewa RM . 2000. Review on apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease. Neurotoxicity Research, 2(2–3): 239–250.
null Kuo TL & Yu HY . 1991. Effect of ethanol on the disposition of paraquat. Toxicology Letters, 58(1): 107–115.
null Kuter K , Nowak P , Golembiowska K , Ossowska K . 2010. Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues. Neurochemical Research, 35(8): 1121–1130.
null Kuter K , Smia?owska M , Wieronska J , Zieba B , Wardas J , Pietraszek M , Nowak P , Biedka I , Roczniak W , Konieczny J , Wolfarth S , Ossowska K . 2007. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Research, 1155: 196–207.
null Kwak KA , Lee SP , Yang JY , Park YS . 2018. Current perspectives regarding stem cell-based therapy for Alzheimer's disease. Stem Cells International, 2018: 1–14.
null L'episcopo F , Tirolo C , Peruzzotti-Jametti L , Serapide MF , Testa N , Caniglia S , Balzarotti B , Pluchino S , Marchetti B . 2018. Neural stem cell grafts promote astroglia-driven neurorestoration in the aged Parkinsonian brain via wnt/beta-catenin signaling. Stem Cells, 36(8): 1179–1197.
null Leng LG , Tian ZM . 2016. Transplantation of neural precursor cells in the treatment of Parkinson disease: an efficacy and safety analysis. Turkish Neurosurgery, 26(3): 378–383.
null Perier C , Bove J , Vila M , Przedborski S . 2003. The rotenone model of Parkinson's disease. Trends in Neurosciences, 26(7): 345–346.
null Lei X , Li H , Huang B , Rizak J , Li L , Xu L , Liu L , Wu J , Lü L , Wang Z , Hu YZ , Le WD , Deng XL , Li JL , Yao YG , Xu L , Hu XT , Zhang BR . 2016. 1-methyl-4-phenylpyridinium stereotactic infusion completely and specifically ablated the nigrostriatal dopaminergic pathway in rhesus macaque. PLoS One, 11(1): e0147094.
null Li H , Ding C , Ding Z , Ling M , Wang T , Wang W , Huang B . 2017. 17β-Oestradiol promotes differentiation of human embryonic stem cells into dopamine neurons via cross-talk between insulin-like growth factors-1 and oestrogen receptor β. Journal of Cellular and Molecular Medicine, 21(8): 1605–1618.
null Li H , Lei XG , Huang BH , Rizak JD , Yang LC , Yang SC , Wu J , Lu LB , Wang JH , Yan T , Li HW , Wang ZB , Hu YZ , Le WD , Deng XL , Huang TZ , Li JL , Xu L , Zhang BR , Hu XT . 2015a. A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections. Journal of Neuroscience Methods, 251: 99–107.
null Li W , Chen SD , Li JY . 2015b. Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling. Progress in Neurobiology, 134(5): 161–177.
null Lu HF , Chai C , Lim TC , Leong MF , Lim JK , Gao S , Lim KL , Wan ACA . 2014. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells. Biomaterials, 35(9): 2816–2826.
null Luk KC , Kehm V , Carroll J , Zhang B , O'brien P , Trojanowski JQ , Lee VMY . 2012. Pathological α-synuclein transmission initiates parkinson-like neurodegeneration in nontransgenic mice. Science, 338(6109): 949–953.
null Luo X , Li M , Su B . 2016. Application of the genome editing tool CRISPR/Cas9 in non-human primates. Zoological Research, 37(4): 214–219.
null Malloy KE, Li J , Choudhury GR , Torres A , Gupta S , Kantorak C , Goble T , Fox PT , Clarke GD , Daadi MM . 2017. Magnetic resonance imaging-guided delivery of neural stem cells into the basal ganglia of nonhuman primates reveals a pulsatile mode of cell dispersion. Stem Cells Translational Medicine, 6(3): 877–885.
null Marmion D , Kordower J . 2018. α-Synuclein nonhuman primate models of Parkinson's disease. Journal of Neural Transmission, 125(3): 385–400.
null Morizane A , Kikuchi T , Hayashi T , Mizuma H , Takara S , Doi H , Mawatari A , Glasser MF , Shiina T , Ishigaki H , Itoh Y , Okita K , Yamasaki E , Doi D , Onoe H , Ogasawara K , Yamanaka S , Takahashi J . 2017. MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nature Communications, 8(1): 385–385.
null Niu Y , Guo X , Chen Y , Wang C , Gao J , Yang W , Kang Y , Si W , Wang H , Yang S , Li S , Ji W , Li X . 2015. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys. Human Molecular Genetics, 24(8): 2308–2317.
null Pardal R , Barneo JL . 2012. Neural stem cells and transplantation studies in Parkinson's disease. Advances in Experimental Medicine and Biology, 741(1): 206–216.
null Park JB , Lee JS , Cho BP , K-J Rhee , Baik SK , Kim J , Kang SJ , D-J Park , J-E Oh , Shin HC , Kim YM , Kim HS , Bae KS , Eom YW . 2015. Adipose tissue-derived mesenchymal stem cells cultured at high cell density express brain-derived neurotrophic factor and exert neuroprotective effects in a 6-hydroxydopamine rat model of Parkinson's disease. Genes & Genomics, 37(2): 213–221.
null Parmar M . 2018. Towards stem cell based therapies for Parkinson's disease. Development, 145(1): 201–204.
null Paumier K , Luk K , Manfredsson F , Kanaan N , Lipton J , Collier T , Collier KS , Kemp C , Celano S , Schulz E , Sandoval I , Fleming S , Dirr E , Polinski N , Trojanowski J , Lee V , Sortwell C . 2015. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiology of Disease, 82(3): 185–199.
null Recasens A , Dehay B , Bove J , Carballo-Carbajal I , Dovero S , Perez-Villalba A , P-O Fernagut , Blesa J , Parent A , Perier C , Farinas I , Obeso JA , Bezard E , Vila M . 2014. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Annals of Neurology, 75(3): 351–362.
null Robinson R . 2018. At the bench-amyotrophic lateral sclerosis: in the lab, regulatory T cells slow ALS. Neurology Today, 18(2): 225–231.
null Sanders LH , Greenamyre JT . 2013. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radical Biology and Medicine, 62(3): 111–120.
null Santana M , Palmér T , Simplício H , Fuentes R , Petersson P . 2015. Characterization of long-term motor deficits in the 6-OHDA model of Parkinson's disease in the common marmoset. Behavioural Brain Research, 290(9): 90–101.
null Sarwar N , Ishaq W , Farid G , Shaheen MR , Imran M , Geng M , Hussain S . 2015. Zinc-cadmium interactions: Impact on wheat physiology and mineral acquisition. Ecotoxicology and Environmental Safety, 122(1): 528–536.
null Shirani A , Stuve O . 2018. Natalizumab: Perspectives from the bench to bedside. Cold Spring Harbor Perspectives in Medicine, 8(12): a029066.
null Silvestrini MT , Yin D , Martin AJ , Coppes VG , Mann P , Larson PS , Starr PA , Zeng X , Gupta N , Panter SS , Desai TA , Lim DA . 2015. Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deployment. Molecular Therapy, 23(1): 119–129.
null Skerjanc IS & Wilton S . 2000. Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells. FEBS Letters, 472(1): 53–56.
null Smirnova L , Harris G , Delp J , Valadares M , Pamies D , Hogberg HT , Waldmann T , Leist M , Hartung T . 2016. A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis. Archives of Toxicology, 90(11): 2725–2743.
null Sonntag KC , Song B , Lee N , Jung JH , Cha Y , Leblanc P , Neff C , Kong SW , Carter BS , Schweitzer J , Kim K-S . 2018. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Progress in Neurobiology, 168(2): 1–20.
null Su LY , Li H , Lv L , Feng YM , Li GD , Luo RC , Zhou HJ , Lei XG , Ma L , Li JL , Xu L , Hu XT , Yao YG . 2015. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation. Autophagy, 11(10): 1745–1759.
null Thomson JA , Itskovitz-Eldor J , Shapiro SS , Waknitz MA , Swiergiel JJ , Marshall VS , Jones JM . 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282(5391): 1145–1147.
null Thompson LH , Shane G , Deniz K , Anders BR . 2010. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. European Journal of Neuroscience, 30(4): 625–638.
null Tobón-Velasco JC , Limón-Pacheco JH , Orozco-Ibarra M , Macías-Silva M , Vázquez-Victorio G , Cuevas E , Ali SF , Cuadrado A , Pedraza-Chaverrí J , Santamaría A . 2013. 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors. Toxicology, 304(3): 109–119.
null Trigo DI, del Rey NL , Blesa J . 2018. Novel models for Parkinson's disease and their impact on future drug discovery. Expert Opinion on Drug Discovery, 13(3): 229–239.
null Vaccari C , El Dib R , De Camargo JLV . 2017. Paraquat and Parkinson's disease: a systematic review protocol according to the OHAT approach for hazard identification. Systematic Reviews, 6(1): 98–98.
null Vermilyea SC , Emborg ME . 2018. The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease. Journal of Neural Transmission, 125(3): 365–384.
null Vierboom M , Breedveld E , Hart BA T . 2012. New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis. Expert Opinion on Drug Discovery, 7(4): 315–325.
null Wang HW , Lin LM , He HY , You F , Li WZ , Huang TH , Ma GX , Ma L . 2011. Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. Chinese Medical Journal, 124(10): 1534–1539.
null Wang S , Okun MS , Suslov O , Zheng T , Mcfarland NR , Vedam-Mai V , Foote KD , Roper SN , Yachnis AT , Siebzehnrubl FA , Steindlera DA . 2012. Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains. Brain Research, 1464(1): 61–72.
null Wang ZB , Qin DD , Hu XT . 2017. Engrafted newborn neurons could functionally integrate into the host neuronal network. Zoological Research, 38(1): 5–6.
null Wei JK , Wang WC , Zhai RW , Zhang YH , Yang SC , Rizak J , Li L , Xu LQ , Liu L , Pan MK , Hu YZ , Ghanemi A , Wu J , Yang LC , Li H , Lv LB , Li JL , Yao YG , Xu L , Feng XL , Yin Y , Qin DD , Xu XT , Wang ZB . 2016. Neurons differentiated from transplanted stem cells respond functionally to acoustic stimuli in the awake monkey brain. Cell Reports, 16(4): 1016–1025.
null Weick JP , Liu Y , Zhang SC . 2011. Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network. Proceedings of the National Academy of Sciences of the United States of America, 108(50): 20189–20194.
null Xu J , Wang D , Liu D , Fan Z , Zhang H , Liu O , Ding G , Gao R , Zhang C , Ding Y , Bromberg JS , Chen W , Sun L , Wang S . 2012. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood, 120(15): 3142–3151.
null Yang WL , Wang GH , Wang CE , Guo XY , Yin P , Gao JQ , Tu ZC , Wang ZB , Wu J , Hu XT , Li SH , Li XJ . 2015. Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain. The Journal of Neuroscience, 35(21): 8345–8358.
null Zhang X , Hu D , Shang Y , Qi X . 2019. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Biochimica et Biophysica Acta, 5(1): 67–75.
null Zhang XL , Pang W , Hu XT , Li JL , Yao YG , Zheng YT . 2014. Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress. Zoological Research, 35(6): 447–464.
null Zhao B , Zhang WD , Duan YL , Lu YQ , Cun YX , Li CH , Guo K , Nie WH , Li L , Zhang R , Zheng P . 2015. Filia is an ESC-specific regulator of DNA damage response and safeguards genomic stability. Cell Stem Cell, 16(6): 684–698.
null Zhou L , Cheng Y . 2019. Alpha-lipoic acid alleviated 6-OHDA-induced cell damage by inhibiting AMPK/mTOR mediated autophagy. Neuropharmacology, 155: 98–103.
null Zhou Q , Zhang H , Wu Q , Shi J , Zhou S . 2017. Pharmacological manipulations of autophagy modulate paraquat-induced cytotoxicity in PC12 cells. International Journal of Biochemistry and Molecular Biology, 8(2): 13–22.